Literature DB >> 8708563

In vivo manipulation (depletion versus activation) of testicular macrophages: central and local effects.

F Gaytan1, C Bellido, C Morales, M García, N van Rooijen, E Aguilar.   

Abstract

Testicular macrophages are a relevant cell type for the regulation of Leydig cell steroidogenesis. The availability of liposome technology allows in vivo manipulation of macrophages in order to analyze their role in the regulation of the hypothalamic-pituitary-testicular axis. In this study, adult (70 days of age) and prepubertal (22 days of age) rats were injected intratesticularly with liposomes containing either dichloromethylene diphosphonate (C12MDP) to deplete testicular macrophages or muramyl tripeptide (MTP-PE) to activate them. Control rats were injected with the corresponding volumes of 0.9% NaCl. Animals were killed 10 days after treatment. Adult rats injected bilaterally or unilaterally with C12MDP liposomes showed increased serum LH and testosterone concentrations, as well as increased testosterone concentrations in the testicular interstitial fluid. In unilaterally injected rats, testosterone concentrations in the interstitial fluid were higher in the macrophage-containing testes than in the contralateral, macrophage-depleted testes. Adult rats treated bilaterally with MTP-PE liposomes showed increased numbers of testicular macrophages, whereas the number of Leydig cells was unchanged. Serum LH concentrations were decreased, but no changes were found in testosterone concentrations. Prepubertal rats treated bilaterally with C12MDP liposomes showed decreased numbers of Leydig cells. However, serum LH and testosterone concentrations were increased. Otherwise, prepubertal rats treated bilaterally with MTP-PE liposomes showed increased numbers of macrophages and Leydig cells, as well as increased serum testosterone concentrations. These data suggest that testicular macrophage-derived factors act at two different levels in the pituitary-testicular axis: first, at a central level by inhibiting LH secretion, and secondly, at a local level by stimulating Leydig cell steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708563     DOI: 10.1677/joe.0.1500057

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

Review 1.  Sertoli Cell Immune Regulation: A Double-Edged Sword.

Authors:  Rachel L Washburn; Taylor Hibler; Gurvinder Kaur; Jannette M Dufour
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

2.  Sertoli cells maintain Leydig cell number and peritubular myoid cell activity in the adult mouse testis.

Authors:  Diane Rebourcet; Peter J O'Shaughnessy; Ana Monteiro; Laura Milne; Lyndsey Cruickshanks; Nathan Jeffrey; Florian Guillou; Tom C Freeman; Rod T Mitchell; Lee B Smith
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

3.  Differential role of r-met-hu G-CSF on male reproductive function and development in prepubertal domestic mammals.

Authors:  Pedro M Aponte; Miguel A Gutierrez-Reinoso; Edison G Sanchez-Cepeda; Manuel Garcia-Herreros
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

4.  Human Adipose-derived Pericytes Display Steroidogenic Lineage Potential in Vitro and Influence Leydig Cell Regeneration in Vivo in Rats.

Authors:  Michael Curley; Zaniah N Gonzalez; Laura Milne; Patrick Hadoke; Ian Handel; Bruno Péault; Lee B Smith
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

5.  The roles of testicular c-kit positive cells in de novo morphogenesis of testis.

Authors:  Man Zhang; Hai Zhou; Chunxing Zheng; Jun Xiao; Erwei Zuo; Wujuan Liu; Da Xie; Yufang Shi; Chunlian Wu; Hongyan Wang; Dangsheng Li; Jinsong Li
Journal:  Sci Rep       Date:  2014-08-04       Impact factor: 4.379

Review 6.  Cell-specific ablation in the testis: what have we learned?

Authors:  L B Smith; P J O'Shaughnessy; D Rebourcet
Journal:  Andrology       Date:  2015-10-07       Impact factor: 3.842

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.